These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1901758

  • 1. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.
    Langstein HN, Doherty GM, Fraker DL, Buresh CM, Norton JA.
    Cancer Res; 1991 May 01; 51(9):2302-6. PubMed ID: 1901758
    [Abstract] [Full Text] [Related]

  • 2. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
    Sheppard BC, Venzon D, Fraker DL, Langstein HN, Jensen JC, Norton JA.
    Cancer Res; 1990 Jul 01; 50(13):3928-33. PubMed ID: 2354441
    [Abstract] [Full Text] [Related]

  • 3. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
    Stovroff MC, Fraker DL, Swedenborg JA, Norton JA.
    Cancer Res; 1988 Aug 15; 48(16):4567-72. PubMed ID: 3165053
    [Abstract] [Full Text] [Related]

  • 4. Insulin reversal of cancer cachexia in rats.
    Moley JF, Morrison SD, Norton JA.
    Cancer Res; 1985 Oct 15; 45(10):4925-31. PubMed ID: 3896470
    [Abstract] [Full Text] [Related]

  • 5. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
    Cahlin C, Körner A, Axelsson H, Wang W, Lundholm K, Svanberg E.
    Cancer Res; 2000 Oct 01; 60(19):5488-93. PubMed ID: 11034092
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cytokines in experimental cancer cachexia].
    Niu Q, Li T, Liu A.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 01; 23(5):382-4. PubMed ID: 11810767
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism and treatment of cancer cachexia in tumor-bearing mice].
    Li T, Li C.
    Zhonghua Zhong Liu Za Zhi; 1997 May 01; 19(3):188-91. PubMed ID: 10920893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of insulin on doxorubicin-induced rat host toxicity and tumor regression.
    Peacock JL, Gorschboth CM, Norton JA.
    Cancer Res; 1987 Aug 15; 47(16):4318-22. PubMed ID: 3300963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gluconeogenesis in the tumor-influenced rat hepatocyte: importance of tumor burden, lactate, insulin, and glucagon.
    Inculet RI, Peacock JL, Gorschboth CM, Norton JA.
    J Natl Cancer Inst; 1987 Nov 15; 79(5):1039-46. PubMed ID: 3316783
    [Abstract] [Full Text] [Related]

  • 15. Comparison of animal models for head and neck cancer cachexia.
    Cannon T, Couch M, Yin X, Guttridge D, Lai V, Shores C.
    Laryngoscope; 2007 Dec 15; 117(12):2152-8. PubMed ID: 17921906
    [Abstract] [Full Text] [Related]

  • 16. Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS.
    Arsenijevic D, Garcia I, Vesin C, Vesin D, Arsenijevic Y, Seydoux J, Girardier L, Ryffel B, Dulloo A, Richard D.
    Eur Cytokine Netw; 2000 Dec 15; 11(4):662-8. PubMed ID: 11125311
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia.
    Byerley LO, Lee SH, Redmann S, Culberson C, Clemens M, Lively MO.
    Nutr Cancer; 2010 Dec 15; 62(4):484-94. PubMed ID: 20432169
    [Abstract] [Full Text] [Related]

  • 19. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
    Grunfeld C, Wilking H, Neese R, Gavin LA, Moser AH, Gulli R, Serio MK, Feingold KR.
    Cancer Res; 1989 May 15; 49(10):2554-60. PubMed ID: 2713842
    [Abstract] [Full Text] [Related]

  • 20. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
    Tracey KJ, Morgello S, Koplin B, Fahey TJ, Fox J, Aledo A, Manogue KR, Cerami A.
    J Clin Invest; 1990 Dec 15; 86(6):2014-24. PubMed ID: 2254457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.